QPPV.COM KNOWLEDGE ASSESSMENT

Amoxicillin: Discovery, Development, Safety and Pharmacovigilance

Test your understanding of the concepts covered by Amoxicillin: Discovery, Development, Safety and Pharmacovigilance.

Question 1 of 10Pass mark: 80%

Question 1 of 10 A child develops repeated vomiting about two hours after amoxicillin, without rash or wheeze, and has had a similar episode after a prior course. What is the most appropriate pharmacovigilance interpretation?
Question 2 of 10 What is the most defensible use of the 1973 bacteriuria study in a current product-history assessment?
Question 3 of 10 The Irish SmPC names Kounis syndrome, whereas the inspected US sections do not separately name it. What is the most appropriate interpretation?
Question 4 of 10 What is the most accurate interpretation of Beecham’s 6-aminopenicillanic acid (6-APA) work in the history of amoxicillin?
Question 5 of 10 A safety review uses adverse-event data from amoxicillin/clavulanate studies to characterise amoxicillin monotherapy. What is the key concern?
Question 6 of 10 A reviewer cites the 1972 volunteer comparison of oral amoxicillin and ampicillin to claim that amoxicillin produces better outcomes for every infection. What is the principal limitation of that inference?
Question 7 of 10 A clinician argues that amoxicillin must be superior to other options because it became widely used after its early studies. Which response best reflects the article’s evidence-based reasoning?
Question 8 of 10 A serious suspected reaction is reported with incomplete clinical details. What should the safety team do?
Question 9 of 10 A patient taking amoxicillin and probenecid has increased amoxicillin exposure. Which mechanism is most consistent with the article?
Question 10 of 10 Which statement best describes pharmacovigilance responsibility across multiple marketing authorisation holders for amoxicillin products?

Select an answer to continue.

QPPV.com